Last update 21 Nov 2024

GQ-1007

Overview

Basic Info

Drug Type
Immune stimulating antibody conjugate (ISAC)
Synonyms
GQ1007
Target
HER2
Mechanism
HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists), Immunogenetic stimulants
Therapeutic Areas
Neoplasms
Active Indication
Neoplasms
Inactive Indication-
Originator Organization
GeneQuantum Healthcare (Suzhou) Co. Ltd.GeneQuantum Healthcare (Suzhou) Co. Ltd.
Active Organization
BrightGene Bio-Medical Technology Co., Ltd.BrightGene Bio-Medical Technology Co., Ltd.GeneQuantum Healthcare (Suzhou) Co. Ltd.GeneQuantum Healthcare (Suzhou) Co. Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

1
Clinical Trials associated with GQ-1007
ACTRN12622000513718 / WithdrawnPhase 1
A Phase I, First-In-Human, Multicenter, Open-Label, Dose Escalation and Expansion Study of GQ1007 Alone and in Combination with Envafolimab in Subjects with HER2-expressing Advanced Solid Tumors
100 Clinical Results associated with GQ-1007
Login to view more data
100 Translational Medicine associated with GQ-1007
Login to view more data
100 Patents (Medical) associated with GQ-1007
Login to view more data
100 Deals associated with GQ-1007
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPhase 1
AU
GeneQuantum Healthcare (Suzhou) Co. Ltd.GeneQuantum Healthcare (Suzhou) Co. Ltd.
15 May 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free